Klas I. Udekwu
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 6
- Endocrinology top 2%
- Escherichia coli research studies 5
- Pollution top 2%
- Biological Psychiatry top 5%
-
- Gut microbiota and health 7
- RNA and protein synthesis mechanisms 3
-
- Bacterial Genetics and Biotechnology 7
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Bacteriophages and microbial interactions 5
-
- Bacterial Identification and Susceptibility Testing 4
- Co-authors
- Bruce R. LevinE. Gerhart H. WagnerEmilio I. AlarcónMay GriffithJörg VogelFabien DarfeuilleJohan ReimegårdErik Holmqvist
- Partner nations
- SwedenUnited StatesCanada
In The Last Decade
Klas I. Udekwu
36 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 142
- Molecular Medicine 286
- Endocrinology 189
- Pollution 407
- Biological Psychiatry 68
- Industrial and Manufacturing Engineering 165
Countries citing papers authored by Klas I. Udekwu
This map shows the geographic impact of Klas I. Udekwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klas I. Udekwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klas I. Udekwu more than expected).
Fields of papers citing papers by Klas I. Udekwu
This network shows the impact of papers produced by Klas I. Udekwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klas I. Udekwu. The network helps show where Klas I. Udekwu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Klas I. Udekwu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2020 | 54 | |
| 4 | 2020 | 35 | |
| 5 | 2019 | 65 | |
| 6 | 2019 | 49 | |
| 7 | 2019 | 16 | |
| 8 | 2019 | 14 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 1 | |
| 11 | 2017 | 12 | |
| 12 | 2016 | 210 | |
| 13 | 2014 | 59 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 191 | |
| 16 | 2012 | 41 | |
| 17 | 2012 | 8 | |
| 18 | 2011 | 39 | |
| 19 | 2010 | 15 | |
| 20 | 2005 | 251 |
About Klas I. Udekwu
Klas I. Udekwu is a scholar working on Molecular Medicine, Endocrinology and Clinical Biochemistry, having authored 38 papers that have together received 2.2k indexed citations. Recurring topics across this work include Gut microbiota and health (7 papers), Bacterial Genetics and Biotechnology (7 papers), Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Escherichia coli research studies (5 papers), Bacteriophages and microbial interactions (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Molecular Medicine (286 citations), Endocrinology (189 citations) and Pollution (407 citations). Klas I. Udekwu has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Bruce R. Levin, E. Gerhart H. Wagner, Emilio I. Alarcón, May Griffith, Jörg Vogel, Fabien Darfeuille, Johan Reimegård, Erik Holmqvist, Martin Ogonowski and Elena Gorokhova. Their work appears in journals such as Nucleic Acids Research, Nature Genetics and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.